Beneficial Bancorp, Inc., incorporated on August 11, 2014, is a stock holding company of Beneficial Bank (the Bank). The Bank is a Pennsylvania chartered bank. As of December 31, 2016, the Bank offered consumer and commercial banking services to individuals, businesses and nonprofit organizations through 63 offices throughout the Philadelphia and Southern New Jersey area. The Company offers traditional financial services to consumers and businesses in its market areas. The Company offers insurance brokerage and investment advisory services through its subsidiaries, Beneficial Insurance Services, LLC and Beneficial Advisors, LLC, respectively. As of December 31, 2016, the Company operated over 40 full-service banking offices in Bucks, Chester, Delaware, Montgomery and Philadelphia Counties, Pennsylvania and 23 full-service banking offices in Burlington, Gloucester and Camden Counties, New Jersey. The Company also operates a lending office in Montgomery County, Pennsylvania. In addition, Beneficial Insurance Services, LLC, operates an office in Montgomery County, Pennsylvania, and provides property, causality, life, health and professional liability insurance to its customers. ...
+See MoreSharpe-Lintner-Black CAPM alpha (Premium Members Only) Fama-French (1993) 3-factor alpha (Premium Members Only) Fama-French-Carhart 4-factor alpha (Premium Members Only) Fama-French (2015) 5-factor alpha (Premium Members Only) Fama-French-Carhart 6-factor alpha (Premium Members Only) Dynamic conditional 6-factor alpha (Premium Members Only) Last update: Saturday 17 January 2026
2024-05-05 10:31:00 Sunday ET

Stock Synopsis: Pharmaceutical post-pandemic patent development cycle In terms of stock market valuation, the major pharmaceutical sector remains at its
2018-12-17 08:43:00 Monday ET

Apple files an appeal to overturn the recent iPhone sales ban in China due to its patent infringement of Qualcomm proprietary technology. This recent ban of
2019-01-10 17:31:00 Thursday ET

The recent Bristol-Myers Squibb acquisition of American Celgene is the $90 billion biggest biotech deal in history. The resultant biopharma goliath would be
2019-05-01 09:27:00 Wednesday ET

Apple settles its 2-year intellectual property lawsuit with Qualcomm by agreeing to a multi-year patent license with royalty payments to the microchip maker
2017-08-13 09:36:00 Sunday ET

Several investors and billionaires such as George Soros, Warren Buffett, Carl Icahn, and Howard Marks suggest that the time may be ripe for a major financia
2025-09-14 14:23:00 Sunday ET

Stock Synopsis: With a new Python program, we use, adapt, apply, and leverage each of the mainstream Gemini Gen AI models to conduct this comprehensive fund